Contact and place of performance
Matthew Poulin
Not specified
No narrative description provided for this notice.
The Department of Veterans Affairs, NAC Pharmaceuticals (36E797), issued an award notice for Bevacizumab Injection under solicitation number 36E79725R0019. This requirement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals. The base year of performance for this award is scheduled to begin on August 13, 2025, and conclude on August 12, 2026.
Matthew Poulin is the designated point of contact for this award, which carries the contract identifier 36E79725D0030. The notice was published on April 11, 2025, and includes one attachment titled 36E79725D0030_1.docx.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.